Ariceum Therapeutics
Berlin, Germany · Health and Medical
Do you work at Ariceum Therapeutics?
Claim this profile to manage your company.
Verified by Enterprise League
Data quality
Complete · Accuracy
Ariceum Therapeutics is a Health and Medical company based in Berlin, Germany, founded in 2021, with 10-20 employees. Ariceum Therapeutics's profile is verified on Enterprise League.
Overview
Ariceum Therapeutics is a private clinical-stage radiopharmaceutical company focused on the diagnosis and precision treatment of neuroendocrine and certain other aggressive, hard-to-treat cancers.
Our lead targeted systemic radiopharmaceutical product, 177 Lu-satoreotide tetraxetan (Satoreotide), is an antagonist of the somatostatin type 2 receptor (SSTR2) which is overexpressed in many neuroendocrine tumours. We are developing satoreotide as a ‘theranostic’ pair for the combined diagnosis and targeted radionuclide treatment of neuroendocrine cancers, certain aggressive tumours and childhood cancer, which currently has few treatment options and a poor prognosis.
Ariceum Therapeutics was launched in 2021, following the acquisition of all rights to our lead product from subsequent shareholder, Ipsen.
Headquartered in Berlin, Ariceum has operations in Germany and is active across Europe, North America and Australia.
Contact Details
info@ariceum-therapeutics.com
Berlin, Germany
Founded
2021
Employees
10-20
Companies teams usually look at after Ariceum Therapeutics
Comparing a few options usually leads to better decisions
Save companies to compare later. Useful when sharing options with your team
This is how your company profile looks to others.